Ten eleven translocation enzymes and 5-hydroxymethylation in mammalian development and cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-4419-9967-2_3PMID 22956496
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biochemical Characterization of Recombinant β-Glucosyltransferase and Analysis of Global 5-Hydroxymethylcytosine in Unique Genomes

  2012cited by this paper
• Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome.

  2012cited by this paper
• Quantitative Sequencing of 5-Methylcytosine and 5-Hydroxymethylcytosine at Single-Base Resolution

  2012cited by this paper
• Low values of 5‐hydroxymethylcytosine (5hmC), the “sixth base,” are associated with anaplasia in human brain tumors

  2012cited by this paper
• TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics.

  2011cited by this paper
• TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm

  2011cited by this paper
• 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells

  2011cited by this paper
• Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA

  2011cited by this paper
• Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development.

  2011cited by this paper
• Different Binding Properties and Function of CXXC Zinc Finger Domains in Dnmt1 and Tet1

  2011cited by this paper
• TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity

  2011cited by this paper
• Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation

  2011cited by this paper
• Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells

  2011cited by this paper
• The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes

  2011cited by this paper
• Acute depletion of Tet1-dependent 5-hydroxymethylcytosine levels impairs LIF/Stat3 signaling and results in loss of embryonic stem cell identity

  2011cited by this paper
• Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.

  2011cited by this paper
• A sensitive mass spectrometry method for simultaneous quantification of DNA methylation and hydroxymethylation levels in biological samples.

  2011cited by this paper
• Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice

  2011cited by this paper
• Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells.

  2011cited by this paper
• Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells.

  2011cited by this paper
• Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain.

  2011cited by this paper
• Tissue-specific Distribution and Dynamic Changes of 5-Hydroxymethylcytosine in Mammalian Genomes*

  2011cited by this paper
• Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers

  2011cited by this paper
• Distribution of 5-Hydroxymethylcytosine in Different Human Tissues

  2011cited by this paper
• Comparative characterization of the PvuRts1I family of restriction enzymes and their application in mapping genomic 5-hydroxymethylcytosine

  2011cited by this paper
• Characterization of PvuRts1I endonuclease as a tool to investigate genomic 5–hydroxymethylcytosine

  2011cited by this paper
• Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine

  2011cited by this paper
• Mbd3/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells.

  2011cited by this paper
• Detection of 5-hydroxymethylcytosine in a combined glycosylation restriction analysis (CGRA) using restriction enzyme Taq(α)I.

  2011cited by this paper
• Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera

  2011cited by this paper
• Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

  2011cited by this paper
• Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells.

  2011cited by this paper
• 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming.

  2011cited by this paper
• TET genes: new players in DNA demethylation and important determinants for stemness.

  2011cited by this paper
• Thymine DNA Glycosylase Can Rapidly Excise 5-Formylcytosine and 5-Carboxylcytosine

  2011cited by this paper
• DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria

  2011cited by this paper
• Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine

  2011cited by this paper
• Impact of TET2 mutations on mRNA expression and clinical outcomes in MDS patients treated with DNA methyltransferase inhibitors

  2011cited by this paper
• Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine

  2011cited by this paper
• TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.

  2011cited by this paper
• CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.

  2011cited by this paper
• Discrimination of methylcytosine from hydroxymethylcytosine in DNA molecules.

  2011cited by this paper
• Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells

  2011cited by this paper
• Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA

  2010cited by this paper
• Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission.

  2010cited by this paper
• Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias

  2010cited by this paper
• Tissue Distribution of 5-Hydroxymethylcytosine and Search for Active Demethylation Intermediates

  2010cited by this paper
• Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1.

  2010cited by this paper
• The Behaviour of 5-Hydroxymethylcytosine in Bisulfite Sequencing

  2010cited by this paper
• Epigenetic Reprogramming in Plant and Animal Development

  2010cited by this paper
• Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

  2010cited by this paper
• Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification

  2010cited by this paper
• Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.

  2010cited by this paper
• The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.

  2010cited by this paper
• Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

  2010cited by this paper
• Genome-Wide Reprogramming in the Mouse Germ Line Entails the Base Excision Repair Pathway

  2010cited by this paper
• Active DNA demethylation: many roads lead to Rome

  2010cited by this paper
• In vitro derivation of germ cells from embryonic stem cells in mammals

  2010cited by this paper
• Significance of JAK2 and TET2 mutations in myelodysplastic syndromes.

  2010cited by this paper
• TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine

  2010cited by this paper
• Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.

  2010cited by this paper
• Direct detection of DNA methylation during single-molecule, real-time sequencing

  2010cited by this paper
• The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain

  2009cited by this paper
• Oxygenase catalyzed 5-methylcytosine hydroxylation.

  2009cited by this paper
• TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

  2009cited by this paper
• Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia

  2009cited by this paper
• Neuronal Activity–Induced Gadd45b Promotes Epigenetic DNA Demethylation and Adult Neurogenesis

  2009cited by this paper
• The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group.

  2009cited by this paper
• Therapeutic targeting of MLL.

  2009cited by this paper
• Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.

  2009cited by this paper
• Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates

  2009cited by this paper
• TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

  2009cited by this paper
• Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

  2009cited by this paper
• Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.

  2009cited by this paper
• Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids

  2009cited by this paper
• Myelodysplastic syndromes.

  2009cited by this paper
• Acquired mutations in TET2 are common in myelodysplastic syndromes

  2009cited by this paper
• Mutation in TET2 in myeloid cancers.

  2009cited by this paper
• TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

  2009cited by this paper
• Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1

  2009cited by this paper
• TET proteins in malignant hematopoiesis

  2009cited by this paper
• Mutation in TET2 in myeloid cancers.

  2009cited by this paper
• Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML

  2009cited by this paper
• REBASE—a database for DNA restriction and modification: enzymes, genes and genomes

  2009cited by this paper
• Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years

  2008cited by this paper
• Cyclical DNA methylation of a transcriptionally active promoter

  2008cited by this paper
• The protein that binds to DNA base J in trypanosomatids has features of a thymidine hydroxylase

  2007cited by this paper
• PGC7/Stella protects against DNA demethylation in early embryogenesis

  2007cited by this paper
• Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1.

  2007cited by this paper
• A type IV modification dependent restriction nuclease that targets glucosylated hydroxymethyl cytosine modified DNAs.

  2007cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Oxidative DNA modifications.

  2005cited by this paper
• Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2).

  2004cited by this paper
• Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements

  2003cited by this paper
• TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23)

  2003cited by this paper
• LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23).

  2002cited by this paper
• Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region.

  2002cited by this paper
• Promoter-specific Activation and Demethylation by MBD2/Demethylase*

  2002cited by this paper
• Dynamic reprogramming of DNA methylation in the early mouse embryo.

  2002cited by this paper
• Epigenetic Reprogramming in Mammalian Development

  2001cited by this paper

• The Impact of Modifiable Risk Factors on the Endothelial Cell Methylome and Cardiovascular Disease Development

  2025cites this paper
• Pan-cancer analyses reveal molecular and clinical characteristics of TET family members and suggests that TET3 maybe a potential therapeutic target

  2024cites this paper
• Pan-cancer analyses reveal the molecular and clinical characteristics of TET family members and suggests that TET3 maybe a potential therapeutic target

  2024cites this paper
• Relative expression of key genes involved in nucleic acids methylation in Anopheles gambiae sensu stricto

  2023cites this paper
• Aberrant Epigenetic Regulation of RARβ by TET2 is Involved in Cutaneous Squamous Cell Carcinoma Resistance to Retinoic Acid.

  2022cites this paper
• TDG regulates cell cycle progression in human neural progenitors [version 1; peer review: 2 approved with reservations]

  2022cites this paper
• The function of non-coding RNAs in idiopathic pulmonary fibrosis

  2021cites this paper
• DNA methylation signature as a biomarker of major neuropsychiatric disorders.

  2021cites this paper
• Selective loss of 5hmC promotes neurodegeneration in the mouse model of Alzheimer's disease

  2020cites this paper
• Pol β gap filling, DNA ligation and substrate-product channeling during base excision repair opposite oxidized 5-methylcytosine modifications.

  2020cites this paper
• Pol β gap filling, DNA ligation and substrate-product channeling during base excision repair opposite oxidized 5-methylcytosine modifications.

  2020cites this paper
• Epigenetik

  2020cites this paper
• Expression Patterns for TETs, LGR5 and BMI1 in Cancer Stem-like Cells Isolated from Human Colon Cancer

  2019cites this paper
• Alterations in epigenetic regulation contribute to neurodegeneration of ataxia-telangiectasia

  2019cites this paper
• Epigenetics and vascular diseases.

  2019cites this paper
• Functions of intrinsic disorder in proteins involved in DNA demethylation during pre-implantation embryonic development.

  2019cites this paper
• Poly ( ADP-ribosyl ) ation is involved in the epigenetic control of TET 1 gene transcription

  2019cites this paper
• Long Noncoding RNA Can Be a Probable Mechanism and a Novel Target for Diagnosis and Therapy in Fragile X Syndrome

  2019cites this paper
• Epigenetic metalloenzymes.

  2018cites this paper
• Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer

  2018cites this paper
• Epigenetic alterations mediate iPSC-induced normalization of DNA repair gene expression and TNR stability in Huntington's disease cells

  2018cites this paper
• The Progress of Methylation Regulation in Gene Expression of Cervical Cancer

  2018cites this paper
• The TET2 Expression Level Correlates with a Short Relapse Time in Glioblastoma Multiforme

  2018cites this paper
• Ten-eleven translocation 1 dysfunction reduces 5-hydroxymethylcytosine expression levels in gastric cancer cells

  2017cites this paper
• Epigenetic Guardian: A Review of the DNA Methyltransferase DNMT3A in Acute Myeloid Leukaemia and Clonal Haematopoiesis

  2017cites this paper
• Transcriptomics and Epigenomics

  2017cites this paper
• A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro

  2017cites this paper
• Dynamic changes in DNA demethylation in the tree shrew (Tupaia belangeri chinensis) brain during postnatal development and aging

  2017cites this paper
• Current methods of extracellular DNA methylation analysis

  2017cites this paper
• The effects of methionine on TCE-induced DNA methylation and mRNA expression changes in mouse liver

  2017cites this paper
• Autophagy associated cytotoxicity and cellular uptake mechanisms of bismuth nanoparticles in human kidney cells.

  2017cites this paper
• Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation

  2017cites this paper
• Neurodevelopmental Disorders and Environmental Toxicants: Epigenetics as an Underlying Mechanism

  2017cites this paper
• Epigenomics and Proteomics of Brain Disorders

  2017cites this paper
• Epigenetic regulation of oncogenes and tumor suppressors in chronic lymphocytic leukemia

  2017cites this paper
• TDG regulates cell cycle progression in human neural progenitors

  2017cites this paper
• DNA methylation alterations in response to prenatal exposure of maternal cigarette smoking: A persistent epigenetic impact on health from maternal lifestyle?

  2016cites this paper
• Interaction of DNA demethylase and histone methyltransferase upregulates Nrf2 in 5-fluorouracil-resistant colon cancer cells

  2016cites this paper
• Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer*

  2016cites this paper
• Ten-Eleven Translocation Genes are Downregulated in Endometriosis.

  2016cites this paper
• Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype

  2015cites this paper
• Circulating biomarker panels for targeted therapy in brain tumors.

  2015cites this paper
• Epigenetics and the overhealing wound: the role of DNA methylation in fibrosis

  2015cites this paper
• Identification of the Polycomb protein CBX2 as a potential drug target in advanced prostate cancer and beyond

  2015cites this paper
• Polycomb-mediated silencing in neuroendocrine prostate cancer

  2015cites this paper
• [Generation of blood circulating DNA: the sources, peculiarities of circulation and structure].

  2015cites this paper
• Causes of genome instability: the effect of low dose chemical exposures in modern society.

  2015cites this paper
• [Generation of blood circulating DNA: the sources, peculiarities of circulation and structure].

  2015cites this paper
• The role of epigenomics in the neurodegeneration of ataxia-telangiectasia.

  2015cites this paper
• Registered report: Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

  2015cites this paper
• DNMT3A: the DioNysian MonsTer of acute myeloid leukaemia

  2014cites this paper
• Poly(ADP-ribosyl)ation is involved in the epigenetic control of TET1 gene transcription

  2014cites this paper
• Epigenetics of Stress, Addiction, and Resilience: Therapeutic Implications

  2014cites this paper
• Trichloroethylene-Induced Gene Expression and DNA Methylation Changes in B6C3F1 Mouse Liver

  2014cites this paper
• Decreased expression of ten-eleven translocation 1 protein is associated with some clinicopathological features in gastric cancer.

  2014cites this paper
• Altered global methylation and hydroxymethylation status in vulvar lichen sclerosus: further support for epigenetic mechanisms

  2014cites this paper
• Standard DNA methylation analysis in mouse epidermis: bisulfite sequencing, methylation-specific PCR, and 5-methyl-cytosine (5mC) immunological detection.

  2014cites this paper
• TET enzymatic oxidation of 5-methylcytosine, 5-hydroxymethylcytosine and 5-formylcytosine.

  2014cites this paper
• Natural Polyphenols as Potent Inhibitors of DNA Methyltransferases

  2014cites this paper
• Epigenetic shielding: 5-hydroxymethylcytosine and 5-carboxylcytosine modulate UV induction of DNA photoproducts

  2014cites this paper
• Generation of blood circulating DNAs: Sources, features of struction and circulation

  2014cites this paper
• TET 1,2,3 and TDG demethylate DNA

  2014cites this paper
• Functional analysis of 5-hydroxymethylcytosine

  2014cites this paper
• Regulation of the catalytic activity and specificity of DNA nucleotide methyltransferase 1

  2014cites this paper
• Integrating DNA methylation dynamics into a framework for understanding epigenetic codes

  2014cites this paper
• New advances of DNA methylation in liver fibrosis, with special emphasis on the crosstalk between microRNAs and DNA methylation machinery.

  2013cites this paper
• Epigenetics, vitamin supplements and cellular reprogramming

  2013cites this paper
• Breast Cancer Epigenetics: Biomarkers and Therapeutic Potential

  2013cites this paper
• Chromatin organisation in breast cancer

  2013cites this paper
• Methods to investigate 5- hydroxymethylcytosine in monozygotic twins discordant for Psoriasis

  2013cites this paper
• Identification of TET1 Partners That Control Its DNA-Demethylating Function.

  2013cites this paper
• Conference scene: 2nd cancer epigenetics conference.

  2013cites this paper
• Epigenetics and aging.

  2013cites this paper
• Prolonged Treatment with DNMT Inhibitors Induces Distinct Effects in Promoters and Gene-Bodies

  2013cites this paper
• Why do primordial germ cells migrate through an embryo and what does it mean for biological evolution?

  2013cites this paper
• eview pigenetics and aging atrizia

  2012cites this paper
• Epigenetic regulation of gene expression

  2010cites this paper